193 related articles for article (PubMed ID: 7172424)
1. Studies of components of the coagulation systems in normal individuals and septic shock patients.
Smith-Erichsen N; Aasen AO; Gallimore MJ; Amundsen E
Circ Shock; 1982; 9(5):491-7. PubMed ID: 7172424
[TBL] [Abstract][Full Text] [Related]
2. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
3. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
4. Studies on pathological plasma proteolysis in patients with septicemia.
Aasen AO; Smith-Erichsen N; Amundsen E
Scand J Clin Lab Invest Suppl; 1985; 178():37-45. PubMed ID: 3867120
[TBL] [Abstract][Full Text] [Related]
5. Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock.
Hack CE; Wagstaff J; Strack van Schijndel RJ; Eerenberg AJ; Pinedo HM; Thijs LG; Nuijens JH
Thromb Haemost; 1991 May; 65(5):497-503. PubMed ID: 1871710
[TBL] [Abstract][Full Text] [Related]
6. [Hyperdynamic septic shock in man: concentration course of selected coagulation factors and plasma proteins].
Witte J; Schiessler H; Scherer R; Jochum M; Schramm W; Fritz H
Chir Forum Exp Klin Forsch; 1979; ():55-9. PubMed ID: 456150
[TBL] [Abstract][Full Text] [Related]
7. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
8. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
[TBL] [Abstract][Full Text] [Related]
9. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
Rao AK; Schmaier AH; Colman RW
Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
[No Abstract] [Full Text] [Related]
10. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
11. [Differential determination of fibrinogen degradation products in assessment of the stages of plasma consumption in patients with infection and liver cirrhosis].
Raschka C; Róka L
Leber Magen Darm; 1993 Jan; 23(1):31-4. PubMed ID: 8445974
[TBL] [Abstract][Full Text] [Related]
12. Treatment of sepsis in the surgical patient evaluated by means of chromogenic peptide substrate assays.
Smith-Erichsen N; Aasen AO; Amundsen E
Acta Chir Scand Suppl; 1982; 509():33-8. PubMed ID: 6187146
[TBL] [Abstract][Full Text] [Related]
13. Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock--comparison with cardiogenic shock.
Martínez-Brotóns F; Oncins JR; Mestres J; Amargós V; Reynaldo C
Thromb Haemost; 1987 Aug; 58(2):709-13. PubMed ID: 3672421
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.
Hesselvik F; Brodin B; Blombäck M; Cedergren B; Lieden G; Maller R
Scand J Clin Lab Invest Suppl; 1985; 178():67-74. PubMed ID: 3937220
[TBL] [Abstract][Full Text] [Related]
15. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
16. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
Lämmle B; Tran TH; Ritz R; Duckert F
Am J Clin Pathol; 1984 Oct; 82(4):396-404. PubMed ID: 6206713
[TBL] [Abstract][Full Text] [Related]
17. Enzymological aspects of blood coagulation.
Kisiel W; Fujikawa K
Behring Inst Mitt; 1983 Aug; (73):29-42. PubMed ID: 6689603
[TBL] [Abstract][Full Text] [Related]
18. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
Egberg N; Hellgren M
Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118
[TBL] [Abstract][Full Text] [Related]
19. [Antithrombin III substitution in patients in shock].
Vinazzer H; Blauhut B; Bergmann H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
[TBL] [Abstract][Full Text] [Related]
20. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.
Kalter ES; Daha MR; ten Cate JW; Verhoef J; Bouma BN
J Infect Dis; 1985 Jun; 151(6):1019-27. PubMed ID: 2582065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
